What Changed at Gleamer

Every material change AI Health Index has tracked at Gleamer: new modules, model and architecture updates, clinical evidence, regulatory status, security certifications, and integration depth. Each entry states what changed, cites its source, and carries our read on what it means for a buyer. The graded assessment of this vendor across all fifteen capability axes sits on its index profile.

Funding rounds, valuations, and awards are not product changes and are not logged here. Acquisitions appear only where there is direct product impact.

Impact
Type
1 entry
Showing changes for Gleamer only.Show the full log

August 2026

G
Gleamer
Aug 5, 2026
HighPartially Verified
Regulatory / FDA

The FDA granted 510(k) clearance to Gleamer's BoneView AI software for pediatric fracture detection. This expands the tool's authorized use to include pediatric populations in clinical settings.

Our read

Expanding FDA clearance to pediatric patients allows health systems and imaging centers to utilize BoneView across a broader demographic, improving diagnostic confidence and standardizing trauma care for children.

Related axis: FDA and Regulatory StatusTrade pressView source